Menu

Latest Pharma Insights


Teamsters Ask Stockholders To Replace Cardinal Health Chairman
The International Brotherhood of Teamsters say that Cardinal Health CEO George Barrett failed to set the correct "tone at the...
Medtech Insight - October 18, 2017
Change At Helm As Tissue Regenix Enters Next Growth Phase
Regenerative medicine firm Tissue Regenix is now seeking a new CEO following the departure of Anthony Odell. The change in...
Medtech Insight - October 18, 2017
EU Commission May Open Floodgates By Inviting Input On Editorial Errors
The European Commission is planning to invite comments on editorial mistakes within the EU's new medtech regulations. But will it...
Medtech Insight - October 18, 2017
genedrive Signs Sysmex To Distribute Decentralized-Setting HCV Test
Molecular diagnostics company genedrive has signed a distribution agreement with Sysmex Corporation to distribute its CE-marked HepC (HCV) ID kit...
Medtech Insight - October 18, 2017
J&J Wins Reversal Of $72M Talc Verdict, Signaling Whole New Ballgame
What has seemed an endless queue of plaintiffs waiting to litigate claims against J&J in Missouri for alleged talc harm...
The Rose Sheet - October 18, 2017
UK R&D Centre for Antimicrobial Resistance Goes Into Battle
The UK's recently launched AMR Centre has launched two R&D collaborations and plans two more this year.
Scrip - October 18, 2017
Silence Seeks Share Of Alnylam RNAi Success In Legal Action
The UK firm believes its siRNA stabilisation chemistryis represented in several late-stage RNAi studies and that market leader Alnylam requires a license that could...
Scrip - October 18, 2017
Lynparza Partners AZ And Merck & Co Target US Breast Cancer Market
AstraZeneca and Merck & Co's strategic collaboration on the development of olaparib and other anticancers has the US breast cancer...
Scrip - October 18, 2017
Consultation To Help Determine Whether EU SPC Framework Fit For Purpose
The European Commission has launched a consultation on proposals to “recalibrate” supplementary protection certificates and patent research exemptions.
The Pink Sheet - October 18, 2017
Pharma’s ‘No-Show’ At Regulatory Meetings In India: Who Loses?
Regulators in India routinely face flak over lengthy approval timelines, but drug firms failing to show up at pre-scheduled regulatory...
The Pink Sheet - October 18, 2017
Bariatric Devices: Intragastric Balloons To Eclipse Gastric Banding
The market for minimally invasive weight loss devices will reach more than $290 million by 2021, according to a new...
IN VIVO - October 18, 2017
Execs On The Move, October 2017
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
IN VIVO - October 18, 2017
Momentum For ViroMed's Gene Therapy After ‘Exceptional’ Trial Go-Ahead In China
China FDA has granted earlier-than-expected approval to begin a Phase III clinical trial of ViroMed's gene therapy VM202. Successful trials...
Scrip - October 18, 2017
Ukraine Nod Paves Way For Panacea Sales To 49 Other Nations
Panacea Biotec has received another piece of good news as it strives to return to profit – this time from...
Scrip - October 18, 2017
Crucial EU Meeting Today To Set Out MDR/IVDR Implementation Work
Implementation of the EU's new highly-detailed Medical Device and IVD Regulations will greatly challenge EU regulatory groups. The work plan...
Medtech Insight - October 18, 2017
Start-Up Spotlight: Lumicell, Shining The Light On Real-Time, Intraoperative Tumor Detection
With its coffers topped up and a new CEO in place, Lumicell is forging ahead with clinical trials of its...
Medtech Insight - October 18, 2017

UK R&D Centre for Antimicrobial Resistance Goes Into Battle
The UK's recently launched AMR Centre has launched two R&D collaborations and plans two more this year.
Scrip - October 18, 2017
Silence Seeks Share Of Alnylam RNAi Success In Legal Action
The UK firm believes its siRNA stabilisation chemistryis represented in several late-stage RNAi studies and that market leader Alnylam requires a license that could...
Scrip - October 18, 2017
Lynparza Partners AZ And Merck & Co Target US Breast Cancer Market
AstraZeneca and Merck & Co's strategic collaboration on the development of olaparib and other anticancers has the US breast cancer...
Scrip - October 18, 2017
Momentum For ViroMed's Gene Therapy After ‘Exceptional’ Trial Go-Ahead In China
China FDA has granted earlier-than-expected approval to begin a Phase III clinical trial of ViroMed's gene therapy VM202. Successful trials...
Scrip - October 18, 2017
Ukraine Nod Paves Way For Panacea Sales To 49 Other Nations
Panacea Biotec has received another piece of good news as it strives to return to profit – this time from...
Scrip - October 18, 2017

Consultation To Help Determine Whether EU SPC Framework Fit For Purpose
The European Commission has launched a consultation on proposals to “recalibrate” supplementary protection certificates and patent research exemptions.
The Pink Sheet - October 18, 2017
Pharma’s ‘No-Show’ At Regulatory Meetings In India: Who Loses?
Regulators in India routinely face flak over lengthy approval timelines, but drug firms failing to show up at pre-scheduled regulatory...
The Pink Sheet - October 18, 2017

Bariatric Devices: Intragastric Balloons To Eclipse Gastric Banding
The market for minimally invasive weight loss devices will reach more than $290 million by 2021, according to a new...
IN VIVO - October 18, 2017
Execs On The Move, October 2017
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
IN VIVO - October 18, 2017

Teamsters Ask Stockholders To Replace Cardinal Health Chairman
The International Brotherhood of Teamsters say that Cardinal Health CEO George Barrett failed to set the correct "tone at the...
Medtech Insight - October 18, 2017
Change At Helm As Tissue Regenix Enters Next Growth Phase
Regenerative medicine firm Tissue Regenix is now seeking a new CEO following the departure of Anthony Odell. The change in...
Medtech Insight - October 18, 2017
EU Commission May Open Floodgates By Inviting Input On Editorial Errors
The European Commission is planning to invite comments on editorial mistakes within the EU's new medtech regulations. But will it...
Medtech Insight - October 18, 2017
genedrive Signs Sysmex To Distribute Decentralized-Setting HCV Test
Molecular diagnostics company genedrive has signed a distribution agreement with Sysmex Corporation to distribute its CE-marked HepC (HCV) ID kit...
Medtech Insight - October 18, 2017
Crucial EU Meeting Today To Set Out MDR/IVDR Implementation Work
Implementation of the EU's new highly-detailed Medical Device and IVD Regulations will greatly challenge EU regulatory groups. The work plan...
Medtech Insight - October 18, 2017
Start-Up Spotlight: Lumicell, Shining The Light On Real-Time, Intraoperative Tumor Detection
With its coffers topped up and a new CEO in place, Lumicell is forging ahead with clinical trials of its...
Medtech Insight - October 18, 2017

J&J Wins Reversal Of $72M Talc Verdict, Signaling Whole New Ballgame
What has seemed an endless queue of plaintiffs waiting to litigate claims against J&J in Missouri for alleged talc harm...
The Rose Sheet - October 18, 2017

Japan Tobacco gains Japanese rights to Opko's Rayaldee for SHPT
Japan Tobacco Inc. licensed exclusive Japanese development and commercialization rights to the secondary hyperparathyroidism treatment (SHPT) Rayaldee (calcifediol) from EirGen Pharma Ltd., a subsidiary of Opko Health Inc.
Strategic Transactions - October 14, 2017
BioDelivery Sciences enters non-exclusive license with Teva for sale of generic Bunavail
As part of a patent litigation settlement, Teva Pharmaceutical Industries Ltd. received a non-exclusive license from BioDelivery Sciences International Inc. to sell generic Bunavail (buprenorphine/naloxone) buccal film for opioid dependence in the US beginning on July 23, 2028.
Strategic Transactions - October 14, 2017
Back to the top Back to the top